Phase 2 Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years old who have been diagnosed with retinitis pigmentosa (RP), either through genetic testing or clinical assessment.
- People whose vision in at least one eye meets a minimum level of 1/60 (a measure of very limited but present vision — confirm exact meaning with trial site).
- People whose eye condition and general health have been stable for the past six months.
- People who are able to read, understand, and sign a written consent form agreeing to take part.
Who may not be able to join:
- People who have other significant eye conditions, such as advanced glaucoma or diabetic retinopathy.
- People who have had eye surgery within the past six months, or who are currently taking part in another drug trial or using an experimental medication.
- People who have certain ongoing health conditions that could affect the study results, such as uncontrolled diabetes or autoimmune diseases.
- People who are currently pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dr. Passant Sayed Saif, PhD ophthalmology, Associate prof of Ophthalmology Misr University for science and technology
Phone: +447473922553
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in BVCA
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.